Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases
出版年份 2017 全文链接
标题
Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases
作者
关键词
Direct oral anticoagulants, Non-vitamin K antagonist oral anticoagulants, Non-valvular atrial fibrillation, Critical bleeding, Emergency procedures, Anticoagulation reversal
出版物
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
Volume 43, Issue 3, Pages 306-317
出版商
Springer Nature
发表日期
2017-02-16
DOI
10.1007/s11239-017-1476-2
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH
- (2016) J. H. Levy et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Managing reversal of direct oral anticoagulants in emergency situations
- (2016) Harry R. Büller et al. THROMBOSIS AND HAEMOSTASIS
- Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trial
- (2016) James D. Douketis et al. THROMBOSIS RESEARCH
- Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab - a case report
- (2016) Johannes Sebastian Mutzenbach et al. Annals of Clinical and Translational Neurology
- Novel oral anticoagulants and reversal agents: Considerations for clinical development
- (2015) Troy C. Sarich et al. AMERICAN HEART JOURNAL
- Overview of the New Oral Anticoagulants: Opportunities and Challenges
- (2015) C. H. Yeh et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Idarucizumab
- (2015) John W. Eikelboom et al. CIRCULATION
- Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
- (2015) Hein Heidbuchel et al. EUROPACE
- Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis
- (2015) Daniel Caldeira et al. HEART
- Idarucizumab for Dabigatran Reversal
- (2015) Charles V. Pollack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran
- (2015) Paul A. Reilly et al. THROMBOSIS AND HAEMOSTASIS
- The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis
- (2014) C. Chai-Adisaksopha et al. BLOOD
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now